株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

MediPoint:核磁気共鳴画像(MRI)装置−−欧州市場の分析と予測

MediPoint: Magnetic Resonance Imaging Systems - EU Analysis and Market Forecasts

発行 GlobalData 商品コード 322144
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
MediPoint:核磁気共鳴画像(MRI)装置−−欧州市場の分析と予測 MediPoint: Magnetic Resonance Imaging Systems - EU Analysis and Market Forecasts
出版日: 2014年12月31日 ページ情報: 英文 179 Pages
概要

世界のMRI(核磁気共鳴画像)市場は変革期の只中にあり、ことに資本設備市場は飽和状態に達し、多数の企業が革新的製品を開発しています。他方、MRIはその登場以来、安全性・効率性の高さや非侵襲的手法が評価されて、導入規模が拡大し続けています。画像技術の急速な進歩や安全技術の発展が、潜在的な治療対象領域の拡大につながってきました。フランスでは低磁場MRI市場はまだ成立していませんが、中磁場・高磁場MRI市場は今後の大幅成長が予想されています。MRI装置市場そのものが、フランスで最も急速に成長している市場部門の一つで、2020年には1億8100万米ドルにまで規模が拡大すると予想されています。他方、英国の高磁場MRI装置市場は、医療費償還制度の未整備や、最先端システムの導入の遅れなどにより、2013年段階で3080万米ドルと、欧州で最も小さな市場となっています。

当レポートでは、欧州諸国の核磁気共鳴画像(以下MRI)装置市場について分析し、装置の技術的特性や市場構造、現在のアンメットニーズ、主な市場促進・抑制要因、今後の市場機会、現在開発中の主要製品、地域全体および主要国における市場動向(過去3年間の実績値と今後7年間の予測値)、製品カテゴリー別の詳細動向、主要企業のプロファイルなどを調査しております。

第1章 目次

第2章 イントロダクション

第3章 産業概要

  • MRI技術の概要
  • システム概要
    • 前分極MRIシステム
    • 拡散MRI
    • みかけの拡散係数
  • 技術の活用分野
  • MRI検査の臨床上の適応
  • 処置の動向
    • 製品のライフサイクル
  • 技術の利点・欠点
    • 概要
    • MRI技術のSWOT分析
    • MRI装置に関する閉所恐怖症の問題
    • 磁気共鳴画像(MRI) vs. コンピュータ断層撮影(CT)
  • 市場へのアクセス
    • 製品のライフサイクル
    • 購入意思決定
    • 一括購買組織の役割
  • 規制プロセス
  • 現在のMRIの医療費償還の動向
  • 処置の動向
    • 神経学
    • 四肢MRI
    • PET/MRI
    • EU5ヶ国
    • 磁気共鳴血管造影
    • 磁気共鳴分光法
    • 業務時間
    • 規制上の課題/リコール
  • 経済的影響
    • 直接的な費用
    • MRIシステムの価格

第4章 アンメットニーズ

  • 概要
  • 被験者データの保管・管理
  • マルチパラメーターMRI
  • 被験者の快適性にすぐれた、静粛性の高いシステム
  • 高度画像取込ハードウェアのサポート用ソフトウェアの改善
  • スループットの高速化
  • 被験者の快適性の改善

第5章 市場機会の分析

  • 概要
  • スキャンの標準化
  • 各種病院へのMRI導入件数の拡大
  • 心臓用MRIの普及
  • 脳発達研究における高磁場MRI
  • 電力供給が不安定な場合は依然として望ましい永久磁石
  • 脳腫瘍の画像化
  • 冷凍剤フリーの冷却システム
  • 外来検査用の追加スキャナ
  • 乳がん・前立腺がん用MRI
  • がん向け全身MRI
  • クラウドコンピューティングの発達
  • 脳外傷の診断速度を速めるための新技術

第6章 市場促進要因および障壁

  • 概要
  • 促進要因:より高い磁場での画像取込能力の改善
  • 促進要因:老朽化装置からの低画質画像
  • 促進要因:MRI装置の平均年数の古さ
  • 促進要因:老朽化装置からの同質信号取得の難しさ
  • 障壁:機械操作訓練のためのリソースの少なさ
  • 障壁:経済的圧力による新規装置導入規模の縮小
  • 障壁:システムの誤用
  • 障壁:MRIシステムの酷使
  • 障壁:ISO(独立系サービス組織)−−メーカーからのサービス・新規製品販売に取って代わる割安な代替手段
  • 障壁:超伝導MRI磁石メーカー
  • 障壁:MRI処置への医療費償還額の不均一性

第7章 競合評価

  • 主な製品の完全プロファイル
    • Oasis (日立メディコ)
    • Echelon Oval (日立メディコ)
    • Discovery MR750w (GE Healthcare)
    • Optima MR360 Advance (GE Healthcare)
    • Optima MR450w (GE Healthcare)
    • Signa HDxt (GE Healthcare)
    • Vantage Titen (Philips Healthcare)
    • Ingenia (Philips Healthcare)
    • Achieva TX (Philips Healthcare)
    • Magnetom Aera (Siemens Healthcare)
    • Magnetom C! (Siemens Healthcare)
    • Magnetom Spectra (Siemens Healthcare)
    • NSM-S15 (Neusoft Medical Systems)
  • 磁力の強さに基づく分類
    • 低磁場MRI装置
    • 中磁場MRI装置
    • 高磁場MRI装置

第8章 パイプライン評価

  • 11.7T MRI Sytem (Neurospin)
  • Aurora PET/MRI System (Aurora Imaging Technology)
  • Neona (Time Medical)
  • GE 7.0T MRI Scanner (GE Healthcare)
  • Signa PET/MRI (GE Healthcare)

第9章 現在および将来の主要企業

  • 概要
  • Aurora Imaging
  • China Resources Wandong Medical Equipment
  • Esaote S.p.A.
  • Fonar Corporation
  • GE Healthcare
  • 日立メディコ
  • Hologic
  • Mindray
  • Neusoft Medical
  • Ningbo Xingaoyi Medical
  • Philips Healthcare
  • Siemens Healthcare
  • Time Medical
  • 東芝メディカルシステムズ

第10章 戦略的な競合評価

  • 企業別の市場シェア

第11章 市場の展望:市場区分別

  • 国別の市場内訳

第12章 市場の展望:地域別

  • EU5ヶ国
    • EU5カ国の市場シェア:国別
    • EU5ヶ国市場の規模:市場区分別
  • フランス
    • 市場金額(金額ベース):市場区分別
    • MRI装置のインストールベース
  • ドイツ
  • イタリア
  • スペイン
  • 英国

第13章 付録

図表一覧

目次
Product Code: GDME1124CFR

The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.

In France there is no market for low-field MRI system sales, although the market for mid- and high-field systems is expected to undergo significant growth in the coming years. MRI is one of the fastest growing device market segments in the country, and will be valued at over $181m by 2020. Valued at just $30.8m in 2013, the high-field MRI market in the UK is one of the smallest in Europe, due to poor reimbursement and slow adoption of advanced systems.

Scope

  • An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the EU Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving the EU Magnetic Resonance Imaging Systems market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the EU Magnetic Resonance Imaging Systems market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the EU Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview of MRI Technology
  • 3.2. System Overview
    • 3.2.1. Pre-Polarizing MRI Systems
    • 3.2.2. Diffusion MRI
    • 3.2.3. Apparent Diffusion Coefficient
  • 3.3. Applications of Technology
  • 3.4. Clinical Indications for MRI scans
  • 3.5. Procedure Trends
    • 3.5.1. Product Lifecycle
  • 3.6. Advantages and Disadvantages of Technology
    • 3.6.1. Overview
    • 3.6.2. MRI Technology SWOT Analysis
    • 3.6.3. Claustrophobia Issues with MRI Systems
    • 3.6.4. Magnetic Resonance Imaging vs. Computed Tomography
  • 3.7. Market Access
    • 3.7.1. Product Life Cycle
    • 3.7.2. Purchasing Decisions
    • 3.7.3. Role of Group Purchasing Organizations
  • 3.8. Regulatory Process
    • 3.8.1. EU
  • 3.9. Current MRI Reimbursement Trends
    • 3.9.1. EU
    • 3.9.2. France
    • 3.9.3. Germany
    • 3.9.4. Italy
    • 3.9.5. Spain
    • 3.9.6. UK
  • 3.10. Procedure Trends
    • 3.10.1. Neurology
    • 3.10.2. Extremity MRI
    • 3.10.3. PET/MRI
    • 3.10.4. 5EU
    • 3.10.5. Magnetic Resonance Angiography
    • 3.10.6. Magnetic Resonance Spectroscopy
    • 3.10.7. Hours of Operation
    • 3.10.8. Regulatory Issues/Recalls
  • 3.11. Economic Impact
    • 3.11.1. Direct Costs
    • 3.11.2. Pricing of MRI Systems

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Storing and Managing Patient Data
  • 4.3. Multiparametric MRI
  • 4.4. Quieter Systems for Improved Patient Comfort
  • 4.5. Improved Software to Support Advanced Image Acquisition Hardware
  • 4.6. Faster Throughput
  • 4.7. Improvements in Patient Comfort

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Standardization of Scans
  • 5.3. Increased Adoption of MRI Throughout the Hospital
  • 5.4. Cardiac MRI on the Rise
  • 5.5. High-Field MRI in Developing Brains
  • 5.6. Permanent Magnets Still Desirable Where Power Unreliable
  • 5.7. Imaging Brain Tumors
  • 5.8. Cryogen-Free Cooling Systems
  • 5.9. Additional Scanners for Outpatient Exams
  • 5.10. Breast and Prostate Cancer MRI
  • 5.11. Whole-Body MRI for Cancer
  • 5.12. Cloud Computing on the Rise
  • 5.13. New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Improved Imaging Capabilities of Higher Field Strength
  • 6.3. Driver: Low-Quality Images from Older Machines
  • 6.4. Driver: High Average Age of MRI Systems
  • 6.5. Driver: Difficulty of Achieving Homogenous Signals with Older Systems
  • 6.6. Barrier: Fewer Resources for Training on Machines
  • 6.7. Barrier: Economic Pressure Reduces New Systems Volume
  • 6.8. Barrier: Misuse of Systems
  • 6.9. Barrier: Overuse of MRI Systems
  • 6.10. Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM
  • 6.11. Barrier: Supeconducting MRI Magnet Producers
  • 6.12. Barrier: Uneven Reimbursement for MRI Procedures

7. Competitive Assessment

  • 7.1. Full Profiles for Key Products
    • 7.1.1. Oasis (Hitachi)
    • 7.1.2. Echelon Oval (Hitachi)
    • 7.1.3. Discovery MR750w (GE Healthcare)
    • 7.1.4. Optima MR360 Advance (GE Healthcare)
    • 7.1.5. Optima MR450w (GE Healthcare)
    • 7.1.6. Signa HDxt (GE Healthcare)
    • 7.1.7. Vantage Titen (Philips Healthcare)
    • 7.1.8. Ingenia (Philips Healthcare)
    • 7.1.9. Achieva TX (Philips Healthcare)
    • 7.1.10. Magnetom Aera (Siemens Healthcare)
    • 7.1.11. Magnetom C! (Siemens Healthcare)
    • 7.1.12. Magnetom Spectra (Siemens Healthcare)
    • 7.1.13. NSM-S15 (Neusoft Medical Systems)
  • 7.2. Classification Based on Field Strength
    • 7.2.1. Low-Field MRI Systems
    • 7.2.2. Mid-Field MRI Systems
    • 7.2.3. High-Field MRI Systems

8. Pipeline Assessment

  • 8.1. 11.7T MRI System (Neurospin)
    • 8.1.1. Overview
    • 8.1.2. SWOT
  • 8.2. Aurora PET/MRI System (Aurora Imaging Technology)
    • 8.2.1. Overview
    • 8.2.2. SWOT
  • 8.3. Neona (Time Medical)
    • 8.3.1. Overview
    • 8.3.2. SWOT
  • 8.4. GE 7.0T MRI Scanner (GE Healthcare)
    • 8.4.1. Overview
    • 8.4.2. SWOT
  • 8.5. Signa PET/MRI (GE Healthcare)
    • 8.5.1. Overview
    • 8.5.2. SWOT

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Aurora Imaging
    • 9.2.1. Overview
    • 9.2.2. Portfolio Assessment
    • 9.2.3. SWOT Analysis
  • 9.3. China Resources Wandong Medical Equipment
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment
    • 9.3.3. SWOT Analysis
  • 9.4. Esaote S.p.A.
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Fonar Corporation
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. GE Healthcare
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Hitachi Medical Corporation
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Hologic
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Mindray
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Neusoft Medical
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Ningbo Xingaoyi Medical
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Philips Healthcare
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Siemens Healthcare
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Sina Healthcare
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Time Medical
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Toshiba Medical Systems Corporation
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis

10. Stategic Competitive Assessment

  • 10.1. Company Market Share
    • 10.1.1. 5EU
    • 10.1.2. France
    • 10.1.3. Germany
    • 10.1.4. Italy
    • 10.1.5. Spain
    • 10.1.6. UK

11. Market Outlooks by Market Segment

  • 11.1. Market Segment by Country
    • 11.1.1. France
    • 11.1.2. Germany
    • 11.1.3. Italy
    • 11.1.4. Spain
    • 11.1.5. UK

12. Market Outlooks by Geography

  • 12.1. 5EU
    • 12.1.1. 5EU Market Share by Country
    • 12.1.2. 5EU Market Value by Market Segment
  • 12.2. France
    • 12.2.1. Market Value by Market Segment
    • 12.2.2. Installed Base of MRI Systems
  • 12.3. Germany
    • 12.3.1. Market Value by Market Segment
    • 12.3.2. Installed Base of MRI Systems
  • 12.4. Italy
    • 12.4.1. Market Value by Market Segment
    • 12.4.2. Installed Base of MRI Systems
  • 12.5. Spain
    • 12.5.1. Market Value by Market Segment
    • 12.5.2. Installed Base of MRI Systems
  • 12.6. United Kingdom
    • 12.6.1. Market Value by Market Segment
    • 12.6.2. Installed Base of MRI Systems

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Report Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Forecasting Methodology
  • 13.5. Primary Research - Key Opinion Leaders
  • 13.6. Primary Research - Physician and Industry Overviews
    • 13.6.1. Expert Panel Validation
  • 13.7. Physicians & Experts Included in this Study
  • 13.8. About the Authors
    • 13.8.1. Analysts
    • 13.8.2. Global Head of Healthcare
  • 13.9. About MediPoint
  • 13.10. About GlobalData
  • 13.11. Disclaimer

List of Tables

  • Table 1: MRI Procedure Targets
  • Table 2: Indications for an Immediate Emergency MRI
  • Table 3: Advantages and Disadvantages of MRI
  • Table 4: Magnetic Resonance Imaging Technology SWOT Analysis
  • Table 5: Selected Group Purchasing Organizations in the US and EU
  • Table 6: France Average Selling Price by Market Segment (2011-2020), $m
  • Table 7: Germany Average Selling Price by Market Segment (2011-2020), $m
  • Table 8: Italy Average Selling Price by Market Segment (2011-2020), $m
  • Table 9: Spain Average Selling Price by Market Segment (2011-2020), $m
  • Table 10: United Kingdom Average Selling Price by Market Segment (2011-2020), $m
  • Table 11: MRI Applications and Future Market Potential
  • Table 12: SWOT Analysis - Oasis
  • Table 13: SWOT Analysis - Echelon Oval
  • Table 14: SWOT Analysis - Discovery MR750w
  • Table 15: SWOT Analysis - Optima MR360 Advance
  • Table 16: SWOT Analysis - Optima MR450w
  • Table 17: SWOT Analysis - Signa HDxt
  • Table 18: SWOT Analysis - Vantage Titen
  • Table 19: SWOT Analysis - Ingenia
  • Table 20: SWOT Analysis - Achieva TX
  • Table 21: SWOT Analysis - Magnetom Aera
  • Table 22: SWOT Analysis - Magnetom C!
  • Table 23: SWOT Analysis - Magnetom Spectra
  • Table 24: SWOT Analysis - NSM-S15
  • Table 25: SWOT Analysis - Low-Field MRI Systems
  • Table 26: Low-Field MRI Systems
  • Table 27: SWOT Analysis - Mid-Field MRI Systems
  • Table 28: Mid-Field MRI Systems
  • Table 29: SWOT Analysis - High-Field MRI Systems
  • Table 30: High-Field MRI Systems
  • Table 31: SWOT Analysis - 11.7T MRI (Neurospin)
  • Table 32: SWOT Analysis - Aurora PET/MRI System (Aurora Imaging Technology)
  • Table 33: SWOT Analysis - Neona (Time Medical)
  • Table 34: SWOT Analysis - 7.0T MRI Scanner (GE Healthcare)
  • Table 35: SWOT Analysis - Signa PET/MR (GE Healthcare)
  • Table 36: Company Profile - Aurora Imaging
  • Table 37: Aurora Imaging, MRI System Device Portfolio
  • Table 38: SWOT Analysis - Aurora Imaging
  • Table 39: Company Profile - China Resources Wandong Medical Equipment
  • Table 40: China Resources Wandong Medical Equipment, MRI System Device Portfolio
  • Table 41: SWOT Analysis - China Resources Wandong Medical Equipment
  • Table 42: Company Profile - Esaote S.p.A.
  • Table 43: Esaote S.p.A., MRI System Device Portfolio
  • Table 44: SWOT Analysis - Esaote S.p.A.
  • Table 45: Company Profile - Fonar Corporation
  • Table 46: Fonar Corporation, MRI System Device Portfolio
  • Table 47: SWOT Analysis - Fonar Corporation
  • Table 48: Company Profile - GE Healthcare
  • Table 49: GE Healthcare, MRI System Device Portfolio
  • Table 50: SWOT Analysis - GE Healthcare
  • Table 51: Company Profile - Hitachi Medical Corporation
  • Table 52: Hitachi Medical Corporation, MRI System Device Portfolio
  • Table 53: SWOT Analysis - Hitachi Medical
  • Table 54: Company Profile - Hologic
  • Table 55: SWOT Analysis - Hologic
  • Table 56: Company Profile - Mindray
  • Table 57: Mindray, MRI System Device Portfolio
  • Table 58: SWOT Analysis - Mindray
  • Table 59: Company Profile - Neusoft Medical
  • Table 60: Neusoft Medical, MRI System Device Portfolio
  • Table 61: SWOT Analysis - Neusoft Medical
  • Table 62: Company Profile - Ningbo Xingaoyi Medical
  • Table 63: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio
  • Table 64: SWOT Analysis - Ningbo Xingaoyi Magnetism
  • Table 65: Company Profile - Philips Healthcare
  • Table 66: Philips Healthcare, MRI System Device Portfolio
  • Table 67: SWOT Analysis - Philips Healthcare
  • Table 68: Company Profile - Siemens Healthcare
  • Table 69: Siemens Healthcare, MRI System Device Portfolio
  • Table 70: SWOT Analysis - Siemens Healthcare
  • Table 71: Company Profile - Sina Healthcare
  • Table 72: Sina Healthcare, MRI System Device Portfolio
  • Table 73: SWOT Analysis - Sina Healthcare
  • Table 74: Company Profile - Time Medical
  • Table 75: Time Medical, MRI System Device Portfolio
  • Table 76: SWOT Analysis - Time Medical
  • Table 77: Company Profile - Toshiba
  • Table 78: Toshiba, MRI System Device Portfolio
  • Table 79: SWOT Analysis - Toshiba
  • Table 80: 5EU Market Sales for MRI Systems (2012)
  • Table 81: France Market Sales for MRI Systems (2012)
  • Table 82: Germany Market Sales for MRI Systems (2012)
  • Table 83: Italy Market Sales for MRI Systems (2012)
  • Table 84: Spain Market Sales for MRI Systems (2012)
  • Table 85: United Kingdom Market Sales for MRI Systems (2012)
  • Table 86: France Market Segment, 2012 & 2020
  • Table 87: Germany Market Segment, 2012 & 2020
  • Table 88: Italy Market Segment, 2012 & 2020
  • Table 89: Spain Market Segment, 2012 & 2020
  • Table 90: United Kingdom Market Segment, 2012 & 2020
  • Table 91: 5EU Market by Country, 2012 & 2020
  • Table 92: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Table 93: France Market Value Forecast by Market Segment (2011-2020), $m
  • Table 94: France Installed Base of MRI Systems (2011-2020)
  • Table 95: Germany Market Value Forecast by Market Segment (2011-2020), $m
  • Table 96: Germany Installed Base of MRI Systems (2011-2020)
  • Table 97: Italy Market Value Forecast by Market Segment (2011-2020), $m
  • Table 98: Italy Installed Base of MRI Systems (2011-2020)
  • Table 99: Spain Market Value Forecast by Market Segment (2011-2020), $m
  • Table 100: Spain Installed Base of MRI Systems (2011-2020)
  • Table 101: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m
  • Table 102: United Kingdom Installed Base of MRI Systems (2011-2020)
  • Table 103: Primary Research Interviews Completed by Country
  • Table 104: Primary Research Interviews Completed by Designation

List of Figures

  • Figure 1: France Average Selling Price by Market Segment
  • Figure 2: Germany Average Selling Price by Market Segment
  • Figure 3: Italy Average Selling Price by Market Segment
  • Figure 4: Spain Average Selling Price by Market Segment
  • Figure 5: United Kingdom Average Selling Price by Market Segment
  • Figure 6: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013
  • Figure 7: 5EU Market Share for MRI Systems (2012)
  • Figure 8: France Market Share for MRI Systems (2012)
  • Figure 9: Germany Market Share for MRI Systems (2012)
  • Figure 10: Italy Market Share for MRI Systems (2012)
  • Figure 11: Spain Market Share for MRI Systems (2012)
  • Figure 12: United Kingdom Market Share for MRI Systems (2012)
  • Figure 13: France Market Segment, 2012 & 2020
  • Figure 14: Germany Market Segment, 2012 & 2020
  • Figure 15: Italy Market Segment, 2012 & 2020
  • Figure 16: Spain Market Segment, 2012 & 2020
  • Figure 17: United Kingdom Market Segment, 2012 & 2020
  • Figure 18: 5EU Market by Country, 2012 & 2020
  • Figure 19: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Figure 20: France Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 21: France Installed Base of MRI Systems (2011-2020)
  • Figure 22: Germany Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 23: Germany Installed Base of MRI Systems (2011-2020)
  • Figure 24: Italy Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 25: Italy Installed Base of MRI Systems (2011-2020)
  • Figure 26: Spain Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 27: Spain Installed Base of MRI Systems (2011-2020)
  • Figure 28: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 29: United Kingdom Installed Base of MRI Systems (2011-2020)
  • Figure 30: Primary Research Interviews Completed by Country
  • Figure 31: Primary Research Interviews Completed by Designation
Back to Top